Skip to main content

Prevention of Pregnancy

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Sebela Pharmaceuticals
1 program
1
VeraCept Intrauterine Copper ContraceptivePhase 11 trial
Active Trials
NCT02167763Completed300Est. Dec 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Sebela PharmaceuticalsVeraCept Intrauterine Copper Contraceptive

Clinical Trials (1)

Total enrollment: 300 patients across 1 trials

NCT02167763Sebela PharmaceuticalsVeraCept Intrauterine Copper Contraceptive

Comparative Study of the VeraCept Low-Dose Intrauterine Copper Contraceptive vs. the TCu380 Copper IUD

Start: Nov 2013Est. completion: Dec 2017300 patients
Phase 1Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.